Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: November 2011

12 - Which cannabis users develop psychosis?


This chapter explores the policy implications of the evidence on cannabis and psychosis for mental health services, health education about the risks of cannabis use, and public policy toward recreational cannabis use. It is useful to compare the strength of the evidence on cannabis and psychosis with that of observational evidence on relationships between adverse health effects and other types of drug use. These comparisons facilitate more consistent, even-handed appraisals of the comparative strengths and weakness of evidence on the adverse effects of different drugs. Providing credible advice to young people on the mental health risks of cannabis use is complicated by the polarized views on the health risks of cannabis expressed in the larger cannabis policy debate. It seems likely that governments in most developed countries will continue to prohibit cannabis use by adults, regardless of whether they do so by imposing criminal or civil penalties for use.


Appels, M.C., Sitskoorn, M.M., Vollema, M.G. and Kahn, R.S. (2004) Elevated levels of schizotypal features in parents of patients with a family history of schizophrenia spectrum disorders. Schizophr Bull, 30:781–90.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A. and Moffitt, T.E. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 325:1212–3.
Barkus, E. and Lewis, S. (2008) Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychol Med, 38:1267–76.
Caspi, A., Moffitt, T.E., Cannon, M., et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry, 57:1117–27.
Cougnard, A., Marcelis, M., Myin-Germeys, I., et al. (2007) Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med, 37:513–27.
Di Forti, M., Morgan, C., Dazzan, P., et al. (2009) High-potency cannabis and the risk of psychosis. Br J Psychiatry, 195:488–91.
Esterberg, M.L., Goulding, S.M., McClure-Tone, E.B. and Compton, M.T. (2009) Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample. Addict Behav, 34:374–9.
Ferdinand, R.F., Sondeijker, F., van der Ende, J., Selten, J.P., Huizink, A. and Verhulst, F.C. (2005) Cannabis use predicts future psychotic symptoms, and vice versa. Addiction, 100:612–8.
Fergusson, D.M., Horwood, L.J. and Ridder, E.M. (2005) Tests of causal linkages between cannabis use and psychotic symptoms. Addiction, 100:354–66.
Fergusson, D.M., Horwood, L.J. and Swain-Campbell, N.R. (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med, 33:15–21.
G.R.O.U.P. (2011) Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch Gen Psychiatry, 68:138–47.
Hanssen, M., Krabbendam, L., VollemaM., Delespaul, P. and van Os, J. (2006) Evidence for instrument and family-specific variation of subclinical psychosis dimensions in the general population. J Abnorm Psychol, 115:5–14.
Harley, M., Kelleher, I., Clark, al. (2010) Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol Med, 40:1627–34.
Henquet, C., Di Forti, M., Morrison, P., Kuepper, R. and Murray, R.M. (2008) Gene-environment interplay between cannabis and psychosis. Schizophr Bull, 34:1111–21.
Henquet, C., Krabbendam, L., Spauwen, J., et al. (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ, 330:11–15.
Henquet, C., Kuepper, R.Konings, M., Lieb, R., Wittchen, H.-U. and van Os, J. (2009a) Do cannabis and urbanicity interact in causing psychosis?Schizophr Bull, 35:87.
Henquet, C., Murray, R., Linszen, D. and van Os, J. (2005b) The environment and schizophrenia: the role of cannabis use. Schizophr Bull, 31:608–12.
Henquet, C., Rosa, A., Delespaul, P., et al. (2009b) COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life. Acta Psychiatr Scand, 119:156–60.
Houston, J.E., Murphy, J., Adamson, G., Stringer, M. and Shevlin, M. (2008) Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophr Bull, 34:580–5.
Kendler, K.S., Schmitt, E., Aggen, S.H. and Prescott, C.A. (2008) Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry, 65:674–82.
Konings, M., Bak, M., Hanssen, M., van Os., J. and Krabbendam, L. (2006) Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand, 114:55–61.
Konings, M.B., Bakoula, C., et al. (2011) Evidence from two prospective population-based studies that cannabis interacts with childhood trauma in causing psychosis. Submitted Manuscript.
Leweke, F.M., Gerth, C.W., Koethe, D., Nolden, B.M. and Klosterkotter, J. (2007) Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study. Fortschr Neurol Psychiatr, 75:211–9.
Leweke, F.M., Schneider, U., Radwan, M., Schmidt, E. and Emrich, H.M. (2000) Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav, 66:175–81.
MacDonald, A.W., 3rd, Pogue-Geile, M. F., Debski, T.T. and Manuck, S. (2001) Genetic and environmental influences on schizotypy: a community-based twin study. Schizophr Bull, 27:47–58.
Mason, O., Morgan, C.J., Dhiman, S.K., et al. (2009) Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis. Psychol Med. 39:951–6.
Miettunen, J., Tormanen, S., Murray, G.K., et al. (2008) Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry, 192:470–1.
Moore, T.H., Zammit, S., Lingford-Hughes, A., et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370:319–28.
Morgan, C.J. and Curran, H.V. (2008) Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry, 192:306–7.
Murray, R.M., Morrison, P.D., Henquet, C. and Di Forti, M. (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci, 8:885–95.
Potter, D.J., Clark, P. and Brown, M.B. (2008) Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci, 53:90–4.
Raine, A. (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull, 17:555–64.
Selten, J.P. and Cantor-Graae, E., (2005) Social defeat: risk factor for schizophrenia?Br J Psychiatry, 187:101–2.
Smith, N. (2005) High potency cannabis: the forgotten variable. Addiction, 100:1558–60; author reply 1560–1.
van Os, J., Bak, M., Hanssen, M., Bijil, R.V., de Graaf, R. and Verdoux, H. (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol, 156:319–27.
van Winkel, R. and G.R.O.U.P. (2011) Family-based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up. Arch Gen Psychiatry, 68: 148–57.
Veling, W., Mackenbach, J.P., van Os, J. and Hoek, H.W. (2008) Cannabis use and genetic predisposition for schizophrenia: a case-control study. Psychol Med, 38:1251–6.
Verdoux, H., Gindre, C., Sobara, F., Tournier, M. and Swendsen, J.D. (2003a) Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med, 33:23–32.
Verdoux, H., Sorbara, F., Gindre, C., Swendsen, J.D. and van Os., J. (2003b) Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophr Res, 59:77–84.
Williams, J. H., Wellman, N.A. and Rawlins, J.N.P. (1996) Cannabis use correlates with schizotypy in healthy people. Addiction, 91:869–77.
Zammit, S., Spurlock, G., Williams, H., et al. (2007) Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry, 191:402–7.
United Nation Office on Drugs and Crime. UNODC World Drug Report 2009.